Serum Institute on Covid Vaccine

New Delhi: The Serum Institute of India (SII) is likely to start the clinical trials of Novavax's Covid-19 vaccine on children in July. It is also planning to introduce the vaccine 'Covovax' as its version of the US firm Novavax's vaccine…
Read More...

Pune: Amid the shortage of Covid vaccines in the country, Serum Institute of India (SII) has informed the government on Sunday that it shall provide around 10 Crore of Covishield in the month of June. The employees have been working…
Read More...

New Delhi: With the first dose of Covishield vaccine enough level of antibodies gets produced in the body whereas an adequate immune response gets triggered after the second dose of Covaxin, said Director General of Indian Council of…
Read More...

New Delhi: Serum Institute of India CEO Adar Poonawalla has said that the SII never exported vaccines at the cost of the people in India. Defending the move to export vaccines earlier this year by the government and vaccine manufacturers…
Read More...

New Delhi: Serum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 vaccine, Covishield. "As promised, before the end of 2020, @SerumInstIndia has applied for emergency use…
Read More...

Bhubaneswar: Adar Poonawala, Chief Executive Officer (CEO) of Serum Institute of India said that a safe and effective vaccine against COVID-19 may be likely available in India by January 2021. The Serum Institute of India(SII) is in…
Read More...

New Delhi: A further collaboration among the Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, Gavi and the Bill and Melinda Gates Foundation will accelerate the manufacture and delivery of up to 100…
Read More...

Bhubaneswar: Chief Minister Shri Naveen Patnaik today spoke to Adar Poonawalla, CEO of Serum Institute over a video call to discuss on progress of Covid vaccine. The Chief Minister expressed happiness that Serum Institute has partnered…
Read More...